Skip to main content
. 2022 Apr 20;10(6):1899–1907. doi: 10.1002/fsn3.2806

TABLE 1.

Baseline characteristics of the study participants in both groups

Variables Propolis group (N = 26) Placebo group (N = 25) p‐value
Age; years 38.92 ± 12.65 44.92 ± 12.10 .090
Females; n (%) 13 (50%) 14 (56%) .781
Married; n (%) 19 (73.07%) 23 (92%) .076
Academic education; n (%) 10 (38.46%) 11 (44%) .885
Employee; n (%) 20 (77%) 20 (80%) .761
METs; minutes/week 691.50 [196.00–1629.00] 360.00 [173.25–1768.00] .883*
Anxiety score 16.88 ± 11.01 17.68 ± 10.44 .793
Disease duration; years 12.32 ± 10.5 8.31 ± 7.36 .366
IBS Type IBS‐C; n (%) 19 (73.07%) 17 (68%) .764
IBS‐M; n (%) 7 (26.92%) 8 (32%)

Abbreviations: IBS, Irritable bowel syndrome; IBS‐C, Constipation subtype of IBS; IBS‐M, Mixed subtype of IBS; METs, Metabolic equivalents.

Physical activity levels are presented as median [25th, 75th]. Age and duration of IBS are presented as mean±SD; other variables are presented as number (%).

Values were obtained from independent samples t‐test.

Values were obtained from the chi‐square test.

*

Values were obtained from Wilcoxon rank‐sum test.